Anti-SARS-CoV-2 monoclonal antibodies

SARS-CoV-2 neutralizing monoclonal antibodies · Rockefeller University

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Anti-SARS-CoV-2 monoclonal antibodies, covering 2025-03-13 to 2025-10-28. Get the full timeline:

Most recent: Clinical Trial Update: Anti-SARS-CoV-2 Monoclonal Antibodies for Long COVID (COVID-19) [Phase 2]